Human Health and Potential (HHP)

Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.

A profile of the immune responses from Singaporean patients recovered from COVID-19 has revealed an urgent need to update vaccines against new viral variants.

Fine-tuning the levels of three skin cell metabolites could be the key to unlocking treatments for psoriasis and ageing skin.

A deletion in the genome of SARS-CoV-2 variants makes resulting infections milder and could also be a target for future COVID-19 treatments.

A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving the way for future cancer immunotherapies.

A*STAR researchers measure the caloric and nutritional profiles of popular local dishes, revealing that they may be more guilty pleasures than healthy staples.

The identification of a class of inflammatory immune cells offers new opportunities to treat chronic skin conditions.

Non-invasive imaging technology reveals how radiation exposure in the brain, particularly early in life, damages delicate brain tissue.

Scientists create a platform for reliably customising antibody molecular structures, opening the door to more potent and effective antibody medicines.

Researchers discover that the deletion of a gene linked to glucose metabolism leads to smaller pancreatic tumours and better patient survival.

A*STAR researchers blend the physics of particle dynamics with complex computational simulations to gauge the risk of catching COVID-19 in different social settings.

Synthetic DNA molecules could serve as an easy-to-manufacture alternative to traditional antibody-based rapid tests.